POF recognised as a leading Trade Mark Prosecution firm

We are very pleased to announce that we’ve been recognised as a leading Trade Mark Prosecution firm by Asia IP in their 2020 Trade Mark Survey. This achievement is a great reflection of the dedication and hard work of our Trade Mark attorneys. Asia IP determines their rankings via thousands of corporate counsels worldwide, who …
>> Read more

Iron Chef defeated in trade mark cook-off

by

In a recent Australian Trade Mark Office decision, Fuji Television Network Inc, owner of the television show IRON CHEF, has failed in its bid to prevent the registration of IRON CHEF in respect of online food deliveries by Iron Chef Pizza Pty Ltd. Iron Chef is a Japanese themed cook-off television show with a cult following.  The …
>> Read more

Flawed mental function saves the day in patent opposition

by

In a recent Australian Patent Office decision[1], an extension of time to file a complete Australian patent application was allowed despite a third party opposition.  The delegate of the Commissioner of Patents accepted that flawed mental function by the applicant in misunderstanding advice provided by their patent attorney was the cause of missing the deadline.   Extensions …
>> Read more

CSIRO developing technologies and solutions in response to COVID-19

by

The Commonwealth Scientific and Industrial Research Organisation (CSIRO) is urgently investigating and developing new technologies aimed at limiting the spread of COVID-19 infection. One example technology is a new isolation hood device developed by CSIRO to reduce the risk of infectious particle transmission between individuals in close proximity. It is envisioned that the isolation hood …
>> Read more

No compensation for the Commonwealth: Australia v Sanofi

by

In the keenly awaited decision in Commonwealth of Australia v Sanofi1, the Federal Court has dismissed the Commonwealth’s $325 million claim for compensation made against Sanofi arising from a patent infringement suit brought against Apotex Australia (Apotex), the Australian subsidiary of the Canadian generic drug company Apotex Canada. Read more here >>

Congratulations to our new Principals

We are pleased to announce that Dr Mary Munroe and Matthew Ford have been appointed as new Principals, effective from 1 July 2020. POF Board Chair Greg Chambers says “Both Mary and Matt work from our Sydney office. Together they will present a strong leadership team for the growth of Phillips Ormonde Fitzpatrick in this …
>> Read more